2,6-diaminopurine has been researched along with olomoucine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanus, J; Havlícek, L; Leclerc, S; Meijer, L; Shaw, G; Strnad, M; Veselý, J | 1 |
| Angello, JC; Margolis, RL; Palmer, DK | 1 |
2 other study(ies) available for 2,6-diaminopurine and olomoucine
| Article | Year |
|---|---|
Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.
Topics: Animals; CDC2 Protein Kinase; CDC28 Protein Kinase, S cerevisiae; Enzyme Inhibitors; Kinetin; Oocytes; Purines; Roscovitine; Starfish; Tumor Cells, Cultured | 1997 |
2-Aminopurine induces spindle cell morphology in MM14 myoblasts in the absence of differentiation signals.
Topics: 2-Aminopurine; Actins; Animals; Cell Differentiation; Cell Line; Cyclin-Dependent Kinases; GTP Phosphohydrolases; HL-60 Cells; Humans; Kinetin; Mice; Microtubules; Muscles; PC12 Cells; Protein Synthesis Inhibitors; Purines; Rats; Signal Transduction; Spindle Apparatus | 1997 |